Government and Regulatory
According to sources, China is getting close to announcing a revised National Reimbursement Drug List (NRDL), the group of drugs covered by China’s national insurance plan. There will be 300 additions, 130 of which will be chemical drugs. The rest will be traditional Chinese medicines. This is the first update of the NRDL since 2009. Last May, China negotiated....More>>>